Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2

被引：0
|
作者：
Labadie, Sharada S. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
407-ORGN
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2
    Labadie, Sharada
    Dragovich, Peter S.
    Barrett, Kathy
    Blair, Wade S.
    Bergeron, Philippe
    Chang, Christine
    Deshmukh, Gauri
    Eigenbrot, Charles
    Ghilardi, Nico
    Gibbons, Paul
    Hurley, Christopher A.
    Johnson, Adam
    Kenny, Jane R.
    Kohli, Pawan Bir
    Kulagowski, Janusz J.
    Liimatta, Marya
    Lupardus, Patrick J.
    Mendonca, Rohan
    Murray, Jeremy M.
    Pulk, Rebecca
    Shia, Steven
    Steffek, Micah
    Ubhayakar, Savita
    Ultsch, Mark
    van Abbema, Anne
    Ward, Stuart
    Zak, Mark
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7627 - 7633
  • [2] Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2
    Zak, Mark
    Mendonca, Rohan
    Balazs, Mercedesz
    Barrett, Kathy
    Bergeron, Philippe
    Blair, Wade S.
    Chang, Christine
    Deshmukh, Gauri
    DeVoss, Jason
    Dragovich, Peter S.
    Eigenbrot, Charles
    Ghilardi, Nico
    Gibbons, Paul
    Gradl, Stefan
    Hamman, Chris
    Hanan, Emily J.
    Harstad, Eric
    Hewitt, Peter R.
    Hurley, Christopher A.
    Jin, Tian
    Johnson, Adam
    Johnson, Tony
    Kenny, Jane R.
    Koehler, Michael F. T.
    Kohli, Pawan Bir
    Kulagowski, Janusz J.
    Labadie, Sharada
    Liao, Jiangpeng
    Liimatta, Marya
    Lin, Zhonghua
    Lupardus, Patrick J.
    Maxey, Robert J.
    Murray, Jeremy M.
    Pulk, Rebecca
    Rodriguez, Madeleine
    Savage, Scott
    Shia, Steven
    Steffek, Micah
    Ubhayakar, Savita
    Ultsch, Mark
    van Abbema, Anne
    Ward, Stuart I.
    Xiao, Ling
    Xiao, Yisong
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6176 - 6193
  • [3] Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
    Zak, Mark
    Hurley, Christopher A.
    Ward, Stuart I.
    Bergeron, Philippe
    Barrett, Kathy
    Balazs, Mercedesz
    Blair, Wade S.
    Bull, Richard
    Chakravarty, Paroma
    Chang, Christine
    Crackett, Peter
    Deshmukh, Gauri
    DeVoss, Jason
    Dragovich, Peter S.
    Eigenbrot, Charles
    Ellwood, Charles
    Gaines, Simon
    Ghilardi, Nico
    Gibbons, Paul
    Gradl, Stefan
    Gribling, Peter
    Hamman, Chris
    Harstad, Eric
    Hewitt, Peter
    Johnson, Adam
    Johnson, Tony
    Kenny, Jane R.
    Koehler, Michael F. T.
    Kohli, Pawan Bir
    Labadie, Sharada
    Lee, Wyne P.
    Liao, Jiangpeng
    Liimatta, Marya
    Mendonca, Rohan
    Narukulla, Raman
    Pulk, Rebecca
    Reeve, Austin
    Savage, Scott
    Shia, Steven
    Steffek, Micah
    Ubhayakar, Savita
    van Abbema, Anne
    Aliagas, Ignacio
    Avitabile-Woo, Barbara
    Xiao, Yisong
    Yang, Jing
    Kulagowski, Janusz J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) : 4764 - 4785
  • [4] Prevention of Islet Inflammatory Stress with JAK1/JAK2 Inhibitors
    Watson, Eleanor
    Waibel, Michaela
    Trivedi, Prerak
    Pappas, Evan
    Fynch, Stacey
    Sutherland, Robyn
    Kay, Thomas
    Thomas, Helen
    TRANSPLANTATION, 2018, 102 : S370 - S370
  • [5] Preclinical characterization of JAK1/JAK2 inhibitors for treatment of type 1 diabetes
    Scott, N. A.
    Trivedi, P. M.
    Graham, K. L.
    Fynch, S.
    Jenkins, M. R.
    Kay, T. W.
    Thomas, H. E.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 361 - 361
  • [6] Pyrrolo[1,2-f]triazines as JAK2 inhibitors: Achieving potency and selectivity for JAK2 over JAK3
    Harikrishnan, Lalgudi S.
    Kamau, Muthoni G.
    Wan, Honghe
    Inghrim, Jennifer A.
    Zimmermann, Kurt
    Sang, Xiaopeng
    Mastalerz, Harold A.
    Johnson, Walter L.
    Zhang, Guifen
    Lombardo, Louis J.
    Poss, Michael A.
    Trainor, George L.
    Tokarski, John S.
    Lorenzi, Matthew V.
    You, Dan
    Gottardis, Marco M.
    Baldwin, Kathy F.
    Lippy, Jonathan
    Nirschl, David S.
    Qiu, Ruhui
    Miller, Arthur V.
    Khan, Javed
    Sack, John S.
    Purandare, Ashok V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1425 - 1428
  • [7] Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3
    Malerich, Jeremiah P.
    Lam, Jennifer S.
    Hart, Barry
    Fine, Richard M.
    Klebansky, Boris
    Tanga, Mary J.
    D'Andrea, Annalisa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7454 - 7457
  • [8] The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3
    Lee, Sun-Mi
    Yoon, Kyoung Bin
    Lee, Hyo Jeong
    Kim, Jiwon
    Chung, You Kyoung
    Cho, Won-Jea
    Mukai, Chisato
    Choi, Sun
    Kang, Keon Wook
    Han, Sun-Young
    Ko, Hyojin
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5036 - 5046
  • [9] Discovery of CYT387: A potent and selective dual inhibitor of JAK1 and JAK2
    Burns, Christopher J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [10] JAK1/JAK2 degraders based on PROTAC for topical treatment of atopic dermatitis
    Wu, Junchao
    Li, Lisha
    Zhu, Quangang
    Zhang, Tingrui
    Miao, Fengze
    Cui, Zhen
    Dong, Guoqiang
    Tai, Zongguang
    Chen, Zhongjian
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 171
12345